Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological Evaluation.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
04 Jul 2020
Historique:
received: 02 06 2020
revised: 29 06 2020
accepted: 30 06 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 27 3 2021
Statut: epublish

Résumé

New chrysin-De-allyl-Pac-1 hybrid analogues, tethered with variable heterocyclic systems (

Identifiants

pubmed: 32635530
pii: molecules25133063
doi: 10.3390/molecules25133063
pmc: PMC7412250
pii:
doi:

Substances chimiques

(4-benzylpiperazin-1-yl)acetic acid (3-allyl-2-hydroxybenzylidene)hydrazine 0
Allyl Compounds 0
Antineoplastic Agents 0
Flavonoids 0
Hydrazones 0
Piperazines 0
chrysin 3CN01F5ZJ5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Jordan University of Science and Technology
ID : 360/2019
Organisme : University of Toledo
ID : F110760
Organisme : Susan G. Komen
ID : CCR18548498
Pays : United States

Références

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1215-22
pubmed: 15555556
Oncologist. 2006 Apr;11(4):342-57
pubmed: 16614230
Heliyon. 2019 May 14;5(5):e01603
pubmed: 31193218
Nutrients. 2017 Aug 21;9(8):
pubmed: 28825675
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Free Radic Biol Med. 1995 May;18(5):901-8
pubmed: 7797098
Phytochemistry. 1997 Dec;46(8):1349-53
pubmed: 9419900
Eur J Med Chem. 2017 Jun 16;133:365-378
pubmed: 28411546
J Chem Inf Model. 2016 Aug 22;56(8):1399-404
pubmed: 27391578
Eur J Pharm Sci. 2016 Jun 10;88:166-77
pubmed: 26924226
Pharm Biol. 2011 May;49(5):508-15
pubmed: 21501099
Bioorg Med Chem Lett. 2016 Jan 15;26(2):570-574
pubmed: 26670842
Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907
pubmed: 15520809
Toxicol Appl Pharmacol. 2014 Aug 15;279(1):1-7
pubmed: 24848621
Chin J Cancer. 2017 Jun 19;36(1):50
pubmed: 28629389
Front Pharmacol. 2017 Aug 02;8:498
pubmed: 28824426
Int J Biochem Cell Biol. 2010 Jan;42(1):21-4
pubmed: 19782763
J Med Chem. 2009 Sep 24;52(18):5721-31
pubmed: 19708658
Cell Prolif. 2012 Dec;45(6):487-98
pubmed: 23030059
Curr Med Chem. 2007;14(17):1829-52
pubmed: 17627520
Bioorg Med Chem Lett. 2013 Aug 1;23(15):4324-7
pubmed: 23790540
Bioorg Med Chem Lett. 2018 Jul 15;28(13):2244-2249
pubmed: 29853331
Bioorg Med Chem. 2006 May 1;14(9):2966-71
pubmed: 16412650
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Bioorg Med Chem. 2004 Dec 1;12(23):6097-105
pubmed: 15519155
Biochem Pharmacol. 2014 Jun 15;89(4):503-14
pubmed: 24704474
Nat Rev Cancer. 2016 Feb;16(2):99-109
pubmed: 26822577
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690
pubmed: 27184417
Anticancer Agents Med Chem. 2014;14(6):901-9
pubmed: 24521149
Curr Pharm Des. 2020;26(15):1712-1728
pubmed: 32003663
J Chem Inf Model. 2017 Mar 27;57(3):417-427
pubmed: 28165734
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
J Appl Microbiol. 2011 Dec;111(6):1551-8
pubmed: 21972890
Eur J Med Chem. 2017 Sep 29;138:1053-1065
pubmed: 28759878
Biochem Pharmacol. 1988 Jul 1;37(13):2607-11
pubmed: 3390220
Biochim Biophys Acta. 2011 Apr;1813(4):521-31
pubmed: 21195116
Bioorg Med Chem. 2015 May 1;23(9):2148-2158
pubmed: 25842364
Biochem Pharmacol. 2012 Sep 15;84(6):766-74
pubmed: 22750060
Int J Oncol. 2013 Jul;43(1):329-37
pubmed: 23636231
Mol Cell. 2002 Mar;9(3):459-70
pubmed: 11931755
Eur J Med Chem. 2014 Mar 21;75:297-300
pubmed: 24556144
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a008714
pubmed: 23545417
Drug Des Devel Ther. 2019 Jan 22;13:423-433
pubmed: 30774307
Cell Res. 2013 Nov;23(11):1247-8
pubmed: 23979019
J Nutr. 2003 Oct;133(10):3248S-3254S
pubmed: 14519822
Science. 1997 Feb 21;275(5303):1129-32
pubmed: 9027314
Int J Mol Sci. 2010 May 19;11(5):2188-99
pubmed: 20559509
Cancers (Basel). 2019 May 23;11(5):
pubmed: 31126091
J Chem Inf Comput Sci. 2004 May-Jun;44(3):1000-5
pubmed: 15154768
Br J Nutr. 2008 Sep;100(3):542-51
pubmed: 18377686
Expert Opin Drug Discov. 2013 Aug;8(8):1029-47
pubmed: 23646979
J Appl Toxicol. 2014 Jan;34(1):105-12
pubmed: 24122885
J Immunol Methods. 1995 Jul 17;184(1):39-51
pubmed: 7622868
Fitoterapia. 2000 Aug;71 Suppl 1:S117-23
pubmed: 10930722
Nat Chem Biol. 2006 Oct;2(10):543-50
pubmed: 16936720
J Nutr. 2000 Aug;130(8S Suppl):2073S-85S
pubmed: 10917926
Phytother Res. 2008 Mar;22(3):356-61
pubmed: 18058990

Auteurs

Buthina A Al-Oudat (BA)

Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.

Hariteja Ramapuram (H)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Saloni Malla (S)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Suaad A Audat (SA)

Department of Chemistry, College of Science and Arts, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.

Noor Hussein (N)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Jenna M Len (JM)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Shikha Kumari (S)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Mel F Bedi (MF)

Department of Medicinal and Biological Chemistry, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Charles R Ashby (CR)

Department of Pharmaceutical Sciences, College of Pharmacy & Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.

Amit K Tiwari (AK)

Department of Pharmacology and Experimental Therapeutics, College of Pharmacy & Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH